Has James Martuccio, MD received payments from drug or device companies?

Yes. Drug and device makers reported $234 in general payments to James Martuccio, MD across 12 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean James Martuccio, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about James Martuccio, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

James Martuccio, MD

Ophthalmology · Warren, OHNPI 1003817420

Payments from drug & device makers

$234in general payments, 2019–2025

Across 12 payments — averaging $19.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alcon$120
Novartis$40
Kala Pharmaceuticals, Inc.$29
Johnson & Johnson Surgical Vision, Inc.$28
Bausch & Lomb Americas Inc.$18

What the payments were for

Food & beverage$21692%
Education$188%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alcon	5	$120
Novartis	2	$40
Kala Pharmaceuticals, Inc.	2	$29
Johnson & Johnson Surgical Vision, Inc.	2	$28
Bausch & Lomb Americas Inc.	1	$18

How this compares

$234 in reported general payments places this provider in the 20th percentile of 640 ophthalmology providers in Ohio.

See all ophthalmology providers in Ohio →

Medicare billing

Part B allowed, 2024

$170,857

Medicare patients

860

Services billed

9,803

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
LumiganBimatoprost	59	$20,639
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol	112	$12,465
RhopressaNetarsudil Mesylate	35	$11,908
Brimonidine Tartrate	57	$6,783
CombiganBrimonidine Tartrate/Timolol	27	$6,300
Latanoprost	618	$6,146
Alphagan PBrimonidine Tartrate	15	$3,186
Travoprost	17	$2,593
Brinzolamide	28	$2,091
Prednisolone Acetate	89	$1,864
Timolol Maleate	63	$983
Ketorolac Tromethamine	60	$850
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	60	$846
Acetazolamide ErAcetazolamide	16	$601
Dorzolamide Hcl	20	$532

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Warren

John PajkaLima$17.7M
Justis EhlersCleveland$5M
Lawrence SingermanBeachwood$3.9M
Sunil SrivastavaCleveland$2.8M
Daniel MillerCincinnati$2.3M
Jonathan LassCleveland$1.9M
William WileyCleveland$1.9M
Peter KaiserCleveland$1.5M
David RogersColumbus$1.5M
Michael SnyderCincinnati$1.3M

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →